Imagen de Portada

Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis

To explore the prognostic value of serial dynamic contrast-enhanced (DCE) MRI in patients with advanced pulmonary adenocarcinoma undergoing first-line therapy with either tyrosine-kinase inhibitors (TKI) or platinum-based chemotherapy (PBC).

Guardado en:
Detalles Bibliográficos
Autores principales: Rheinheimer, Stephan (Autor) , Christopoulos, Petros (Autor) , Erdmann, Stella (Autor) , Saupe, Julia (Autor) , Golpon, Heiko André (Autor) , Vogel-Claussen, Jens (Autor) , Dinkel, Julien (Autor) , Thomas, Michael (Autor) , Heußel, Claus Peter (Autor) , Kauczor, Hans-Ulrich (Autor) , Heußel, Gudula (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: 05 December 2022
In: BMC medical imaging
Year: 2022, Volumen: 22, Pages: 1-12
ISSN:1471-2342
DOI:10.1186/s12880-022-00943-x
Acceso en línea:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12880-022-00943-x
Verlag, kostenfrei, Volltext: https://bmcmedimaging.biomedcentral.com/articles/10.1186/s12880-022-00943-x
Enlace del recurso
Notas de Autor:Stephan Rheinheimer, Petros Christopoulos, Stella Erdmann, Julia Saupe, Heiko Golpon, Jens Vogel-Claussen, Julien Dinkel, Michael Thomas, Claus Peter Heussel, Hans-Ulrich Kauczor and Gudula Heussel
Descripción
Sumario:To explore the prognostic value of serial dynamic contrast-enhanced (DCE) MRI in patients with advanced pulmonary adenocarcinoma undergoing first-line therapy with either tyrosine-kinase inhibitors (TKI) or platinum-based chemotherapy (PBC).
Notas:Gesehen am 08.11.2023
Descripción Física:Online Resource
ISSN:1471-2342
DOI:10.1186/s12880-022-00943-x

Ejemplares similares